Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru

BACKGROUND: Nearly half of the world’s population is at risk for dengue, yet no licensed vaccine or anti-viral drug is currently available. Dengue is caused by any of four dengue virus serotypes (DENV-1 through DENV-4), and infection by a DENV serotype is assumed to provide life-long protection agai...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS Negl Trop Dis
Päätekijät: Forshey, Brett M., Reiner, Robert C., Olkowski, Sandra, Morrison, Amy C., Espinoza, Angelica, Long, Kanya C., Vilcarromero, Stalin, Casanova, Wilma, Wearing, Helen J., Halsey, Eric S., Kochel, Tadeusz J., Scott, Thomas W., Stoddard, Steven T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2016
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4746126/
https://ncbi.nlm.nih.gov/pubmed/26848841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0004398
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia